Investigating the EPR effect of nanomedicines in human renal tumors via ex vivo perfusion strategy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Investigating the EPR effect of nanomedicines in human renal tumors via ex vivo perfusion strategy
Authors
Keywords
EPR effect, E, x vivo, perfusion, Anticancer nanomedicine, X-ray computed tomography, Cancer therapy
Journal
Nano Today
Volume 35, Issue -, Pages 100970
Publisher
Elsevier BV
Online
2020-09-08
DOI
10.1016/j.nantod.2020.100970
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ligand-Switchable Micellar Nanocarriers for Prolonging Circulation Time and Enhancing Targeting Efficiency
- (2018) Tangjian Cheng et al. ACS Applied Materials & Interfaces
- Surface-adaptive zwitterionic nanoparticles for prolonged blood circulation time and enhanced cellular uptake in tumor cells
- (2018) Hanlin Ou et al. Acta Biomaterialia
- Walking the line: The fate of nanomaterials at biological barriers
- (2018) Huan Meng et al. BIOMATERIALS
- Polymerization-induced self-assembly of large-scale iohexol nanoparticles as contrast agents for X-ray computed tomography imaging
- (2018) Yuxun Ding et al. Polymer Chemistry
- Cancer: A precision approach to tumour treatment
- (2017) Rodrigo Dienstmann et al. NATURE
- Drug development in the era of precision medicine
- (2017) Sarah A. Dugger et al. NATURE REVIEWS DRUG DISCOVERY
- Metabolic reprogramming in clear cell renal cell carcinoma
- (2017) Hiromi I. Wettersten et al. Nature Reviews Nephrology
- Surface-Adaptive, Antimicrobially Loaded, Micellar Nanocarriers with Enhanced Penetration and Killing Efficiency in Staphylococcal Biofilms
- (2016) Yong Liu et al. ACS Nano
- Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
- (2016) Yuko Nakamura et al. BIOCONJUGATE CHEMISTRY
- Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin
- (2016) Grant H. Petersen et al. JOURNAL OF CONTROLLED RELEASE
- To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
- (2016) F. Danhier JOURNAL OF CONTROLLED RELEASE
- CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing
- (2016) Andrew J. Clark et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polymerization-induced self-assembly of block copolymer nanoparticles via RAFT non-aqueous dispersion polymerization
- (2016) Matthew J. Derry et al. PROGRESS IN POLYMER SCIENCE
- The challenges facing block copolymer micelles for cancer therapy: In vivo barriers and clinical translation
- (2015) Sina Eetezadi et al. ADVANCED DRUG DELIVERY REVIEWS
- Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
- (2015) Hiroshi Maeda ADVANCED DRUG DELIVERY REVIEWS
- Cancer nanomedicine: addressing the dark side of the enhanced permeability and retention effect
- (2015) Elizabeth Huynh et al. Nanomedicine
- EPR or no EPR? The billion-dollar question
- (2015) Andrew Z. Wang Science Translational Medicine
- Self-Regulated Multifunctional Collaboration of Targeted Nanocarriers for Enhanced Tumor Therapy
- (2014) Hongjun Gao et al. BIOMACROMOLECULES
- Development, growth, propagation, and angiographic utilization of the rabbit VX2 model of liver cancer: a pictorial primer and “how to” guide
- (2014) Ahmad Parvinian et al. Diagnostic and Interventional Radiology
- EPR: Evidence and fallacy
- (2014) Joseph W. Nichols et al. JOURNAL OF CONTROLLED RELEASE
- Dispersion RAFT polymerization: comparison between the monofunctional and bifunctional macromolecular RAFT agents
- (2014) Chengqiang Gao et al. Polymer Chemistry
- Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?
- (2014) Hisataka Kobayashi et al. Theranostics
- Nano-Sized CT Contrast Agents
- (2013) Nohyun Lee et al. ADVANCED MATERIALS
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
- (2013) U. Prabhakar et al. CANCER RESEARCH
- Mind the gap: A survey of how cancer drug carriers are susceptible to the gap between research and practice
- (2013) Darren Lars Stirland et al. JOURNAL OF CONTROLLED RELEASE
- Poly(iohexol) Nanoparticles As Contrast Agents for in Vivo X-ray Computed Tomography Imaging
- (2013) Qian Yin et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle
- (2013) S. Eliasof et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanotheranostics for personalized medicine
- (2012) Simona Mura et al. ADVANCED DRUG DELIVERY REVIEWS
- X-ray-Computed Tomography Contrast Agents
- (2012) Hrvoje Lusic et al. CHEMICAL REVIEWS
- Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
- (2012) Sebastien Taurin et al. JOURNAL OF CONTROLLED RELEASE
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Macromolecular therapeutics in cancer treatment: The EPR effect and beyond
- (2012) Hiroshi Maeda JOURNAL OF CONTROLLED RELEASE
- Tumor Heterogeneity and Personalized Medicine
- (2012) Dan L. Longo NEW ENGLAND JOURNAL OF MEDICINE
- Recent advances in RAFT dispersion polymerization for preparation of block copolymer aggregates
- (2012) Jiao-Tong Sun et al. Polymer Chemistry
- Theranostic Nanoparticles Engineered for Clinic and Pharmaceutics
- (2011) Xiaowei Ma et al. ACCOUNTS OF CHEMICAL RESEARCH
- Cellular Uptake, Intracellular Trafficking, and Cytotoxicity of Nanomaterials
- (2011) Feng Zhao et al. Small
- EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy
- (2010) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- Tumor delivery of macromolecular drugs based on the EPR effect
- (2010) Vladimir Torchilin ADVANCED DRUG DELIVERY REVIEWS
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
- (2010) Chunbai He et al. BIOMATERIALS
- 'Green' reversible addition-fragmentation chain-transfer (RAFT) polymerization
- (2010) Mona Semsarilar et al. Nature Chemistry
- Strategies in the design of nanoparticles for therapeutic applications
- (2010) Robby A. Petros et al. NATURE REVIEWS DRUG DISCOVERY
- Impact of Nanotechnology on Drug Delivery
- (2009) Omid C. Farokhzad et al. ACS Nano
- Quantitative CT Imaging of the Spatial and Temporal Distribution of Liposomes in a Rabbit Tumor Model
- (2009) Jinzi Zheng et al. MOLECULAR PHARMACEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started